Does ATEZOLIZUMAB Cause Left ventricular hypertrophy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Left ventricular hypertrophy have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.0% of all adverse event reports for ATEZOLIZUMAB.
5
Reports of Left ventricular hypertrophy with ATEZOLIZUMAB
0.0%
of all ATEZOLIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From ATEZOLIZUMAB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
TACROLIMUS (135)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
Which ATEZOLIZUMAB Alternatives Have Lower Left ventricular hypertrophy Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN